Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats.
Since extremely low frequency (i.e., 50- or 60-Hz) magnetic fields (MFs) from overhead power lines and other electromagnetic sources are ubiquitous in modern societies, the possible carcinogenic effect of such fields recently suggested by epidemiological studies has engendered much concern. However, in view of various unknown and uncontrolled variables which may bias epidemiological studies on MF interactions, a causal relationship between MFs and tumorigenesis can only be determined precisely in animal experiments. The goal of the study reported here was to determine if low frequency MFs at the low flux densities which are relevant for human populations induce tumor-promoting or copromoting effects in a model of breast cancer. Furthermore, since reduction in pineal production of melatonin has been implicated as a cause of tumor promotion by electromagnetic fields, determinations of nocturnal melatonin peak levels in serum were performed during MF exposure. Mammary tumors were induced by intragastric administration of 20 mg (5 mg/week) 7,12-dimethylbenz(a)anthracene (DMBA) in female Sprague-Dawley rats. Groups of 36 rats were either sham-exposed or exposed for 91 days at a 50-Hz gradient MF of 0.3-1 microT, which is a relevant range for elevated domestic MF exposure as arising from neighboring power lines. Nocturnal melatonin levels were significantly reduced by exposure to this weak alternating MF. However, histopathological evaluation of mammary lesions did not disclose any significant difference between MF- and sham-exposed animals. Incidence of mammary tumors was 61% in controls versus 67% in MF-exposed rats. The predominant tumor type was the invasive adenocarcinoma, which was found in 21 rats of both groups. Examination of tumor size did not indicate significant differences in tumor burden between both groups. Furthermore, the incidence of preneoplastic lesions was not altered by MF exposure. Thus, the data of this study indicate that alternating MF do not exert significant tumor promoting or copromoting effects at environmentally relevant flux densities in the rat mammary cancer system.
Löscher
W
W
Department of Pharmacology, Toxicology and Pharmacy, School of Veterinary Medicine, Hannover, FRG.
Wahnschaffe
U
U
Mevissen
M
M
Lerchl
A
A
Stamm
A
A
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004195:Disease Models, Animal; D004574:Electromagnetic Fields / Q000009:adverse effects*; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000209:etiology* / Q000378:metabolism*; D008550:Melatonin / Q000096:biosynthesis* / Q000097:blood; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley
D015127:9,10-Dimethyl-1,2-benzanthracene; D008550:Melatonin